These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36739920)

  • 1. Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular Carcinoma.
    Chamseddine I; Kim Y; De B; Naqa IE; Duda DG; Wolfgang JA; Pursley J; Wo JY; Hong TS; Paganetti H; Koay EJ; Grassberger C
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1234-1243. PubMed ID: 36739920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
    Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
    Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of dose perturbations for metal stent in photon and proton radiotherapy plans for hepatocellular carcinoma.
    Lee B; Cho S; Park HC; Kang SW; Kim JS; Chung JB
    Radiat Oncol; 2022 Jul; 17(1):125. PubMed ID: 35842636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis.
    Cheng JY; Liu CM; Wang YM; Hsu HC; Huang EY; Huang TT; Lee CH; Hung SP; Huang BS
    Radiat Oncol; 2020 Jun; 15(1):159. PubMed ID: 32605627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis.
    Hsieh RC; Lee CH; Huang HC; Wu SW; Chou CY; Hung SP; Lee CW; Krishnan S; Venkatesulu BP; Lee JC; Chou YC; Chan KM; Lin PT; Lee WC; Lin CC; Lin SY; Hong JH
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):712-724. PubMed ID: 37778426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
    Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
    Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton.
    Uchinami Y; Katoh N; Abo D; Morita R; Taguchi H; Fujita Y; Kanehira T; Suzuki R; Miyamoto N; Takao S; Matsuura T; Sho T; Ogawa K; Orimo T; Kakisaka T; Kobashi K; Aoyama H
    Br J Radiol; 2023 Mar; 96(1144):20220720. PubMed ID: 36633335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-volume histogram analysis of patients with hepatocellular carcinoma regarding changes in liver function after proton therapy].
    Tsuji H; Okumura T; Maruhashi A; Hayakawa Y; Matsuzaki Y; Tanaka N; Osuga T; Tsujii H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Apr; 55(5):322-8. PubMed ID: 7784153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
    Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Beam Therapy in Liver Malignancies.
    Siddiqui O; Pollock A; Samanta S; Kaiser A; Molitoris JK
    Curr Oncol Rep; 2020 Feb; 22(3):30. PubMed ID: 32108284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept.
    Price RG; Apisarnthanarax S; Schaub SK; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1349-1356. PubMed ID: 29932945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning prediction of proton and photon dose distributions for paediatric abdominal tumours.
    Guerreiro F; Seravalli E; Janssens GO; Maduro JH; Knopf AC; Langendijk JA; Raaymakers BW; Kontaxis C
    Radiother Oncol; 2021 Mar; 156():36-42. PubMed ID: 33264639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of proton therapy in the treatment of gastrointestinal cancers: liver.
    Dionisi F; Ben-Josef E
    Cancer J; 2014; 20(6):371-7. PubMed ID: 25415681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of CT-image guidance in proton therapy for liver cancer and the importance of daily dose monitoring for tumors and organs at risk.
    Maeda Y; Kobashi K; Sato Y; Tamamura H; Yamamoto K; Matsushita K; Sasaki M; Tatebe H; Asahi T; Matsumoto S; Takamatsu S; Miyazaki K; Fujimoto R; Uchinami Y; Katoh N; Aoyama H
    Med Phys; 2023 Jun; 50(6):3274-3288. PubMed ID: 37099416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of repeated proton beam therapy for patients with hepatocellular carcinoma.
    Oshiro Y; Mizumoto M; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Takizawa D; Sakurai H
    Radiother Oncol; 2017 May; 123(2):240-245. PubMed ID: 28366501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.
    Yoo GS; Yu JI; Park HC
    World J Gastroenterol; 2018 Jul; 24(28):3090-3100. PubMed ID: 30065555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
    Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
    Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients.
    Prayongrat A; Srimaneekarn N; Thonglert K; Khorprasert C; Amornwichet N; Alisanant P; Shirato H; Kobashi K; Sriswasdi S
    Radiat Oncol; 2022 Dec; 17(1):202. PubMed ID: 36476512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.